An interventional study of standard follow-up and PET/CT and EUS in Esophageal Cancer, Stomach Cancer and Pancreatic Cancer, sponsored by Michael Bau Mortensen. Status unknown at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-08-05.
Sponsored by Michael Bau Mortensen · Not applicable, Interventional, and Diagnostic
Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic.
This is because the methods and the consequence of following these patients is unknown.
Therefore the investigators will randomize these patients in to two groups:
Inclusion Criteria:
Outpatient clinic visits 3,6,9,12,18 and 24 mths after surgery
Behavioral: standard follow-up
PET/CT and EUS at 3,6,9,12,18 and 24 months after surgery
Procedure: PET/CT and EUS
Outpatient clinic visits
PET/CT and EUS
Number of patients eligible for treatment
Does early detection of recurrent disease translate in to more patients being eligible for oncologic treatment?
Time frame: 2 years
This study is status unknown, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Michael Bau Mortensen